Integrated biopharma inc (INB)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows provided by operating activities:
Net income

936

959

312

360

923

246

159

818

388

-348

-179

1,536

238

-77

649

747

33

-63

241

-110

-105

547

403

-114

-450

397

298

780

-532

817

-972

-1,554

-737

-785

363

-981

-876

-423

-1

Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization

79

69

91

87

68

75

91

84

82

82

100

95

96

105

97

91

89

80

91

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use assets

108

117

116

115

114

112

112

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of financing instruments and amortization of prepaid financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

75

47

56

57

-

-

-

-

5

226

355

319

Compensation expense on employee stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5

5

9

26

62

158

Financing costs for stock issued in connection with Convertible Note Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

5

Change in fair value of derivative liability

-

-

-

-

-

-

-

-373

-54

-185

118

-212

-92

363

368

-63

130

-6

3

-3

-41

-447

-214

40

-10

-82

73

-469

174

-657

1,085

5

1

-5

-10

-38

42

0

-6

Loss (income) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-217

-406

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

95

93

94

100

103

107

105

106

107

124

136

120

120

133

186

87

85

Accretion of financing instruments and amortization of prepaid financing costs

-

-

-

-

-

-

-

26

27

26

26

27

26

26

26

27

44

61

60

60

59

60

60

60

58

60

59

-

-

-

-

-

-

-

-

-

-

-

-

Stock based compensation

14

15

15

-

-

-

-

2

4

4

4

12

11

22

4

7

7

8

9

104

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in deferred tax assets

-58

-38

-5

-16

37

-19

31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized (gain) loss on investments

90

-31

-24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

4

2

5

-

27

15

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in deferred tax assets

-

-

-

-

-

-

-

-

-43

-301

54

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment charge on investment in iBio, Inc.

-

-

-

-

-

-

-

107

0

168

83

36

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash charge of professional fees incurred in connection with Convertible Note Payable - CD Financial, LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

50

49

49

Gain on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-12

6

-2

6

-3

-2

-1

-60

60

-30

Changes in operating assets and liabilities:
Accounts receivable

-607

1,525

-1,084

-568

440

1,136

-415

640

-1,397

1,922

-1,347

1,313

-1,714

655

630

-468

-358

1,188

165

-168

-599

1,088

119

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-441

547

-1,099

1,144

-221

596

106

632

-707

477

301

-374

-135

Inventories

776

-602

1,073

-1,730

-987

1,936

1,858

-814

497

1,016

-603

-235

54

-254

324

925

-187

931

309

-110

-863

-224

1,276

1,030

-1,132

-725

94

-316

253

1,364

-161

-4,762

942

709

1,005

-1,138

1,535

-1,849

1,044

Other current assets

-

-

-

44

-18

55

-8

31

-25

36

-35

-26

102

-16

-17

118

-53

11

23

-85

31

13

83

-66

38

-10

2

-34

12

-11

-48

809

-141

-60

33

112

-103

113

-70

Operating lease right of use assets

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits and other assets

-

-

18

-

-

-

-52

-

-

29

-48

-

-

-71

0

-

-153

11

-11

-

1

0

-15

-

12

0

-8

-

3

-2

49

-

-1

0

-3

-

-

-

-

Accounts payable

1,853

-848

1,251

-2,181

-1,137

1,128

1,861

-690

-682

1,834

-455

-500

-958

806

-640

-181

-470

491

887

-681

-117

-453

763

730

-143

-576

-258

-637

-508

620

-73

2,356

496

-1,229

-1,975

1,661

1,182

-387

-1,350

Accrued expenses and other liabilities

-2

110

-37

-93

131

128

-70

-212

-47

102

24

64

-282

284

-93

1

61

-41

-347

63

182

93

-109

25

93

-88

157

-176

-141

-156

45

-

-541

-859

1,384

-

125

-84

67

Operating lease obligations

-110

-117

-116

-115

-114

-113

-112

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

223

339

-1,592

436

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-123

-271

Net cash provided from operating activities - discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

782

757

Net cash provided by (used in) operating activities

2,491

-627

1,685

627

615

-1,507

593

-175

703

-964

1,604

-818

668

1,073

-526

-

-

-

-

-

-

-

-495

-220

1,097

231

769

-580

121

-853

-126

-785

270

-473

217

19

-772

659

486

Cash flows from investing activities:
Purchase of property and equipment

57

43

58

64

63

269

18

31

6

103

107

17

227

42

41

69

0

-1

41

8

39

20

168

67

86

27

2

9

13

0

8

73

75

6

1

56

27

73

145

Proceeds from sale of machinery and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

18

-

7

3

2

-

0

0

30

Cash contribution in AgroSport LLC

-

-

-

0

1

-1

8

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-73

-115

Net cash used in investing activities - discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net cash used in investing activities

28

-40

-58

-64

-64

-268

-26

-32

-4

-99

-107

-17

-227

-42

-41

-

-

-

-41

71

-39

-20

-168

-67

-86

-27

-2

-8

-13

0

10

-73

-68

-3

1

-54

-27

-73

-115

Cash flows from financing activities:
Advances under revolving credit facility

11,364

12,786

11,040

13,363

12,675

12,695

10,204

11,041

10,450

9,676

9,997

10,931

11,414

10,484

12,556

11,543

10,601

10,469

8,553

9,353

8,779

10,069

8,792

8,208

6,615

8,628

8,890

9,372

8,266

8,549

8,527

-

-

-

-

-

-

-

-

Proceeds from issuance of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

40

Repayments of advances under revolving credit facility

13,130

12,394

12,075

13,675

12,855

11,067

10,400

10,465

10,921

8,791

10,768

9,961

11,712

11,365

11,881

11,549

12,351

8,722

8,796

9,303

9,796

9,221

8,332

7,508

7,428

8,738

9,089

8,871

8,075

7,652

8,250

-

-

-

-

-

-

-

-

Proceeds from Line of Credit Note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

43

0

23

79

205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments under term note payables

213

128

482

2,548

145

146

184

145

145

125

544

170

144

143

372

170

150

153

147

212

134

135

135

135

135

429

135

135

135

136

90

-

-

-

-

-

-

-

-

Repayments under finance lease obligations

42

55

60

59

73

51

50

58

75

70

30

30

29

33

39

33

24

29

35

35

41

43

24

15

14

10

8

-

-

-

-

0

0

8

12

11

12

11

11

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51

29

Net cash used in financing activities - discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net cash (used in) provided by financing activities

-2,021

209

-1,577

-519

-165

1,455

-430

373

-691

833

-1,345

771

-311

-1,057

264

-

-

-

-382

-197

-1,169

749

506

554

-962

-549

-342

358

53

761

187

354

0

-8

-12

-11

-12

-51

29

Net increase in cash

498

-458

50

44

386

-320

137

166

8

-230

152

-64

130

-26

-303

-55

390

-24

13

-283

306

-246

-157

267

49

-345

425

-230

161

-92

71

-504

202

-484

206

-46

-811

535

400

Decrease (increase) in cash, discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-572

-494

Supplemental disclosures of cash flow information:
Interest paid

95

105

123

61

199

168

201

204

202

196

198

208

204

277

195

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

210

191

171

173

175

188

177

174

179

176

178

183

185

188

172

126

-

259

250

263

-

-

-

-

Income taxes paid

-

-

-

71

70

121

2

91

21

109

0

72

67

110

117

96

18

54

0

112

1

45

0

-

-

-

-

2

2

10

3

-

-

-

3

-

-

-

-

Accretion of discount on Convertible Note Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

20

28

28

28

27

27

28

27

27

27

27

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of prepaid financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

33

32

-

32

33

32

-

32

33

32

-

-

-

-

-

-

-

-

-

-

-

-

Financing on capitalized lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65

70

168

14

0

0

0

185

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-